Business Wire

TX-MARY-KAY

7.1.2022 23:15:07 CET | Business Wire | Press release

Share
Mary Kay Inc. & Mary Kay Ash FoundationSM Celebrate 2021 Year-End Highlights

Mary Kay Inc., a global entrepreneurship development company and advocate for corporate social responsibility and sustainability, today released its year-end highlights. In 2021, Mary Kay Inc. continued its decades-long commitment to enriching the lives of women around the globe and building healthier, more sustainable communities.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220107005500/en/

Learn more about Mary Kay’s 2021 accomplishments in this report .

2021 YEAR-END HIGHLIGHTS

Business Excellence

  • Mary Kay received 58 awards and recognition honors in 2021, including: COVID Response (22 awards), recognition from partners in social impact/annual reports (4), Mary Kay management recognized for leadership (7), business excellence (10) and an award-winning documentary (4 awards; 5 screening selections). Additionally, Mary Kay and/or its iconic founder, Mary Kay Ash, were featured in two Harvard Business Case Studies, three textbooks, and one research paper.
  • Announced the appointment of Wendy Wang as President of its Asia Pacific Region . 54% of Mary Kay’s global executive team is female.
  • Mary Kay markets celebrated anniversaries: Mary Kay Lithuania (10 years) and Mary Kay Germany (35 years).
  • Named one of America's Best Mid-Sized Employers 2021 by Forbes .

Mary Kay Global Design Studio & Digital Innovation to Enhance the Customer Experience

  • Mary Kay Global Design Studio and Glamhive announced the first-ever global TikTok reality show based on style, Step & Repeat . The contest showcased talent in wardrobe, makeup & hair from TikTok users worldwide. Participants showcased their talents from more than 30 countries, and the ground-breaking campaign was featured in the UK Daily Mail , The Daily Front Row , and Vogue Business highlighting its innovative approach to using the relatively new social media platform.
  • Launched Suite 13 , a beauty experience that uses virtual reality to digitize the company's first virtual pop-up showroom; Mary Kay MirrorMe™ for augmented-reality makeovers and Mary Kay® Skin Analyzer App to scan your face for a customized skin care routine.
  • Celebrated 25 years partnering with Global Beauty Ambassador, Luis Casco.

Science Behind the Beauty

  • Clinical Solutions™ skincare launched, which consists of Mary Kay Clinical Solutions™ Retinol 0.5 and Mary Kay Clinical Solutions™ Calm + Restore Facial Milk and received the Dermatologists’ Council Seal.
  • Dr. Michelle Hines, Ph.D., Mary Kay Director of Product Formulation, was announced as president-elect for the Society of Cosmetic Chemists (SCC).
  • In collaboration with Society for Investigative Dermatology (SID), announced Skin Health/Skin Disease Grants. Grants will be awarded to researchers conducting groundbreaking, innovative studies in skin health and skin diseases to uncover new perspectives and intervention strategies.
  • Announced recipients of multiple science educational grants including: the Society of Cosmetic Chemists and Mary Kay Inc. - Madam C.J. Walker Scholarships, in support of under-represented minority students pursuing an undergraduate or graduate degree in chemical, physical, medical, pharmaceutical, biological, or related sciences and technology; and provided five Girls in STEAM grants to young women currently engaged in innovative research. The 2021 recipients included: Mylana Brodovska, Ukraine; Selin Alara Ornek, Turkey; Jordan Reeves, U.S.; Ivanna Hernandez, Colombia; and Allie Weber, U.S.
  • Unveiled research at multiple virtual science conferences. The research included: sharing research on a gradual retinization process that significantly improves tolerance to higher concentrated pure retinol , while still delivering retinol’s key skin benefits; presented the findings for topical application of pure retinol improving hyperpigmentation in an Asian population; and Modulating mechanisms associated with skin barrier function effectively alleviates 2 common concerns associated with sensitive skin.

Social Impact/CSR

  • In 2021, Mary Kay’s global Pink Changing LivesSM cause empowerment program supported over 15 NGOs around the world. Since 2008, the program has impacted more than six million women and their families by partnering with over 3,000 organizations, donating over $16 million.
  • Mary Kay China: China's Henan province was affected by severe flooding. Due to the floods, at least 33 people were killed, 8 others went missing, 200,000 people were evacuated, 3 million people were affected, and the direct economic loss was about $1.22 billion yuan. Mary Kay China donated 1-million-yuan worth of products to Henan Charity Federation.
  • Mary Kay Germany: European floods impacted Germany, Austria, Belgium and the Netherlands and ranked as the most destructive natural hazard in Northern Europe. Mary Kay Germany pledged up to $100,000 euros to support those affected.
  • Mary Kay Spain: In 2020-21, partnered with the Fundación Vicente Ferrer to provide health care access to children and their families in India. Prior to the COVID-19 pandemic (in 2018), Mary Kay Spain financed the construction of a school for children in Pagadalavaripalli village, located in the Kadiri (Anantapur) region of India.

Women’s Empowerment

  • Announced commitment to advancing gender parity by releasing a position paper welcoming the European Commission’s Gender Equality Strategy for 2020 – 2025 and by joining the Generation Equality Forum in Paris and five Global Action Coalitions to accelerate gender equality by 2026.
  • In collaboration with UN Women, ILO & WE Empower, re-released, “Strengthening Support for Women Entrepreneurs in COVID-19 Response and Recovery ” at the Commission on the Status of Women (CSW65).
  • Mary Kay and the Mary Kay Ash FoundationSM were recognized in the Report of the United Nations Entity for Gender Equality and the Empowerment of Women on the activities of the United Nations trust fund in support of actions to eliminate violence against women to the Commission on the Status of Women (CSW65) and Human Rights Council.

Diversity, Equity & Inclusion (DEI)

  • Announced 100% of U.S.-based Directors and above completed mandatory Unconscious Bias training.
  • Released Gender Diversity in the Workplace Data: 54% of Mary Kay’s global executive team is female; 61% of Mary Kay’s global workforce is female; and 54% of Global Vice Presidents and above are female; 59% of Directors and above are female.
  • In collaboration with global partner Equal Rights Trust, announced the launch of innovative research on gender inequality in algorithms and artificial intelligence aimed at addressing equality and gender impacts of algorithmic systems, presented by Mary Kay.

Sustainability

  • Announced global sustainability strategy: Enriching Lives Today for a Sustainable Tomorrow . Our holistic approach encompasses three pillars of sustainability—economic, environmental and social—through five pillars, activated by 15 commitments to deliver a decade of sustainable action.
  • Became a signatory to two crucial causes in protecting our world’s waterways: the CEO Water Mandate and the United Nations Global Compact’s Sustainable Ocean Principles.
  • Joined the Ellen MacArthur Foundation as a member of its Network, as part of its commitment to becoming a more sustainable, circular business.
  • Mary Kay released its second documentary, Forest of Hope , in October during the 2021 UN Climate Change Conference (COP26) . The documentary highlights the work of Angelica, a 70-year eco-warrior and leader of a group of women entrepreneurs committed to saving the forests of Monterrey.
  • Through its partnership with Arbor Day Foundation, the Time for Trees® initiative, announced achieving the commitment to planting 100 million trees and inspiring 5 million new tree planters by April of 2022, was achieved one year ahead of schedule.
  • Mary Kay has partnered with the Nature Conservancy since 1991. In 2021, Mary Kay supported seven projects in the Solomon Islands, Northern Australia, New Zealand, rural China, Mexico, the United States, and Canada.

About Mary Kay

One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company nearly 60 years ago with three goals: develop rewarding opportunities for women, offer irresistible products, and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skin care, color cosmetics, and fragrances. Mary Kay is committed to empowering women and their families by partnering with organizations from around the world, focusing on supporting cancer research, protecting survivors from domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Mary Kay Ash’s original vision continues to shine—one lipstick at a time. Learn more at www.MaryKayGlobal.com .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release

The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod

JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release

JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release

TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye